The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Organic Pharmaceutical Excipients Market Across 2026–2030?
The organic pharmaceutical excipients market has demonstrated significant expansion in recent times. This market is expected to increase from $12.21 billion in 2025 to $13.28 billion in 2026, registering a compound annual growth rate (CAGR) of 8.7%. Key drivers for its past growth include the growth of generic drug manufacturing, rising use of excipients in oral formulations, availability of natural raw materials, increasing pharmaceutical production capacity, and historical preference for proven excipient safety profiles.
The organic pharmaceutical excipients market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $18.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.3%. Key factors driving this growth during the forecast period include the increasing number of biopharmaceutical pipelines, a growing need for sustainable drug formulations, a heightened emphasis on patient-centric formulations, continuous improvements in excipient processing techniques, and more stringent regulations that support non-toxic excipients. Significant trends expected during this period involve a rising preference for plant-based and naturally sourced excipients, an increasing call for clean-label and non-toxic pharmaceutical components, greater incorporation of organic excipients in oral solid dosage forms, the development of functional excipients to improve drug stability and bioavailability, and increasing regulatory backing for naturally derived pharmaceutical additives.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10819&type=smp
What Drivers Are Shaping The Future Growth Of The Organic Pharmaceutical Excipients Market?
The increasing need for pharmaceutical drugs is anticipated to propel the expansion of the organic pharmaceutical excipients market in the future. Pharmaceutical drugs are precisely engineered compounds utilized for diagnosing, treating, preventing, or managing various diseases, achieving their effects by engaging with particular biological mechanisms to reestablish or sustain normal bodily functions. A key contributor to the heightened demand for these drugs is the increasing prevalence of intricate and long-term health issues. These conditions require ongoing medical treatment and stimulate the creation of sophisticated, specific, and readily available therapeutic solutions for sustained patient management. Organic pharmaceutical excipients facilitate this escalating demand by improving drug stability, optimizing delivery, and boosting bioavailability, thus allowing for the effective formulation and functionality of numerous contemporary medicines. As an illustration, in January 2024, data from the New Drug Therapy Approvals 2023 report, issued by the Center for Drug Evaluation and Research (CDER), a US-based division of the U.S. Food and Drug Administration (FDA), indicated that CDER sanctioned 55 novel drugs in 2023, among which 20 (36%) were classified as first-in-class, significantly more than the 37 novel drug approvals in 2022. Consequently, the expanding need for pharmaceutical drugs is driving the growth of the organic pharmaceutical excipients market.
What Segmentation Levels Are Considered In The Organic Pharmaceutical Excipients Market?
The organic pharmaceutical excipients market covered in this report is segmented –
1) By Type: Oleochemicals, Carbohydrates, Protein, Other Types
2) By Functions: Binders, Coating Agents, Colorants, Disintegrates, Other Functions
3) By Application: Oral Formulations, Topical Formulations, Parenteral Formulations, Other Applications
Subsegments:
1) By Oleochemicals: Fatty Acids, Glycerin, Fatty Alcohols, Surfactants, Esters
2) By Carbohydrates: Starch, Cellulose, Dextrins, Sugars, Pectins
3) By Protein: Gelatin, Albumin, Collagen, Casein, Whey Protein
4) By Other Types: Natural Excipients, Inorganic Excipients, Microcrystalline Cellulose
What Trends Are Projected To Affect The Organic Pharmaceutical Excipients Market?
Major companies in the organic pharmaceutical excipients market are concentrating their efforts on creating innovative products, such as label-friendly excipient systems, to satisfy evolving formulation requirements, enhance product transparency, and support clean-label initiatives within health-related consumer markets. A label-friendly excipient system denotes a formulation-supporting material sourced from natural or organic origins, enabling the safe, stable, and effective manufacturing of drugs or supplements while aligning with consumer preferences for minimal, recognizable, and non-synthetic ingredients. For instance, in April 2023, Colorcon, a pharmaceutical excipient provider based in the US, introduced Nutracore, a novel range of label-friendly excipients specifically tailored for nutraceutical and supplement providers. These excipients are manufactured from natural and organic materials to meet the increasing demand for clean labeling in the nutritional and dietary supplement industry, simultaneously ensuring optimal manufacturability and performance. Nutracore excipients empower manufacturers to fulfill consumer expectations for transparent labels without compromising the quality and functionality of their products.
Which Leading Firms Are Contributing To The Growth Of The Organic Pharmaceutical Excipients Market?
Major companies operating in the organic pharmaceutical excipients market are Roquette Frères SA, DuPont de Nemours Inc., Ashland Inc., Kerry Group plc, Evonik Industries AG, Croda International plc, Innophos Holdings Inc., Wacker Chemie AG, Merck KGaA, Colorcon Asia Private Limited, JRS PHARMA GMBH + CO KG, Cargill Incorporated, Ingredion Incorporated, Sensient Technologies Corporation, Lonza Group Ltd., DFE PHARMA INDIA PRIVATE LIMITED., Omya AG, Sigachi Industries Pvt. Ltd., Meggle AG, Archer Daniels Midland Company
Read the full organic pharmaceutical excipients market report here:
Which Geographic Regions Are Influencing Demand In The Organic Pharmaceutical Excipients Market?
North America was the largest region in the global organic pharmaceutical excipients market in 2025. The regions covered in the organic pharmaceutical excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Organic Pharmaceutical Excipients Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10819&type=smp
Browse Through More Reports Similar to the Global Organic Pharmaceutical Excipients Market 2026, By The Business Research Company
Organic Pharmaceutical Excipients Market Report 2026
Pharmaceutical Excipient Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report
Pharmaceutical Chemicals Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-chemicals-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model